Clinical trial
Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent…
NCT00277082 · University of New Mexico, Other · Completed
Key facts
| NCT number | NCT00277082 |
|---|---|
| Title | Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung |
| Official title | Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC) in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung (NSCLC) |
| Lead sponsor | University of New Mexico, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Corpus Uteri, Lung Cancer |
| Intervention type | Drug |
| Interventions | 9-NC in aerosol reservoir |
| Enrollment | 24 |
| Start date | Aug 1, 2003 |
| Completion | Jun 1, 2005 |
| First posted | Jan 13, 2006 |
| Last update posted | Jan 7, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: